| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5622678 | Alzheimer's & Dementia | 2015 | 20 Pages |
Abstract
ADNI has made myriad impacts in its first decade. A competitive renewal of the project in 2015 would see the use of newly developed tau imaging ligands, and the continued development of recruitment strategies and outcome measures for clinical trials.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Michael W. Weiner, Dallas P. Veitch, Paul S. Aisen, Laurel A. Beckett, Nigel J. Cairns, Jesse Cedarbaum, Michael C. Donohue, Robert C. Green, Danielle Harvey, Clifford R. Jr., William Jagust, John C. Morris, Ronald C. Petersen, Andrew J. Saykin,